Trending Articles

article thumbnail

The only tribal medical school in the U.S. graduates its first Native American doctors

STAT

There are so few Indigenous physicians in the United States — just 0.3% of doctors — that their numbers barely show up in charts and graphs depicting the diversity of the medical workforce. But as of Thursday, there will be at least nine more. Thursday is graduation day for the first class of the nation’s only tribally affiliated medical school, the Oklahoma State University College of Osteopathic Medicine at the Cherokee Nation.

article thumbnail

FT US Pharma and Biotech Summit: Live coverage

pharmaphorum

Explore innovation, investment, and policies at the US Pharma and Biotech Summit 2024. Join industry leaders, regulators, and investors to discuss trends shaping healthcare.

90
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Ten pharmacies closing every week, NPA analysis suggests

The Pharmacist

The equivalent of 10 local pharmacies are closing their doors each week, according to analysis by the National Pharmacy Association (NPA). And the number of bricks and mortar pharmacies closing between January and April 2024 is nearly 50% higher than in the same period last year, the NPA said. The association’s analysis of NHS Business […] The post Ten pharmacies closing every week, NPA analysis suggests appeared first on The Pharmacist.

119
119
article thumbnail

Takeda wagers up to $2.2bn on AC Immune Alzheimer’s shot

pharmaphorum

Takeda has made a strong play for a stake in the Alzheimer’s disease market, paying $100 million upfront for an option on AC Immune’s amyloid-targeting immunotherapy. The option fee could be followed by another up to $2.1 billion in potential milestones if Takeda takes global rights to the programme, currently headed by ACI-24.060 which is in a phase 1b/2 trial with new data due in the next few weeks.

Immunity 129
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Ajax, aiming for a better JAK drug, raises $95M to begin first tests

BioPharma Dive

Goldman Sachs and Eli Lilly are among those backing the startup, which claims its prospect could be more potent than the myelofibrosis therapies that have come to market in recent years.

127
127
article thumbnail

When Worlds Collide: The Theory of Real-World Evidence Meets Reality

FDA Law Blog: Biosimilars

By Jeffrey N. Gibbs & Ana Loloei & Véronique Li, Senior Medical Device Regulation Expert — FDA has long touted the use of real-world evidence ( RWE ). Extolling RWE, FDA has said “RWE can be leveraged to bring new products to market, evaluate the safety and effectiveness of existing products for new uses, and assess the continued performance and safety of products once on the market.

More Trending

article thumbnail

BREAKING: Government publishes hub and spoke consultation response

The Pharmacist

Hub and spoke dispensing between pharmacies owned by different legal entities will be allowed from 1 January 2025, subject to parliamentary approval, the government has announced. In its consultation response published today, the government proposed introducing two models of hub and spoke dispensing across legal entities. In one model the hub would directly supply the […] The post BREAKING: Government publishes hub and spoke consultation response appeared first on The Pharmacist.

122
122
article thumbnail

GSK, UK govt put £130m into antimicrobial resistance fight

pharmaphorum

GSK has become the first founding partner of the new Fleming Initiative, which aims to tackle the rising threat of antimicrobial resistance (AMR) and is also backed by the UK government.

104
104
article thumbnail

LogiPharma Europe 2024: World Courier President Talks Mitigating Supply Chain Risks

Pharmaceutical Commerce

In an interview with Pharma Commerce Editor Nicholas Saraceno at LogiPharma Europe, Nick Porter, President, World Courier discusses mitigating supply chain risks, the future of artificial intelligence in pharma logistics, and more.

103
103
article thumbnail

WHO prequalifies new dengue vaccine

Express Pharma

A new vaccine for dengue received prequalification from the World Health Organization (WHO) on May 10, 2024. TAK-003 is the second dengue vaccine to be prequalified by WHO. Developed by Takeda, it is a live-attenuated vaccine containing weakened versions of the four serotypes of the virus that cause dengue. WHO recommends the use of TAK-003 in children aged 6–16 years in settings with high dengue burden and transmission intensity.

article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Drug overdose deaths fell for first time in five years, though still exceeded 100,000

STAT

U.S. drug deaths decreased slightly in 2023, according to new data, the first decrease in five years. Last year saw 107,543 U.S. drug overdose deaths, according to preliminary statistics released Wednesday by the Centers for Disease Control and Prevention, roughly a 3% drop from 2022.

333
333
article thumbnail

NPA hands DHSC giant invoice for '£108m monthly shortfall'

The Pharmacist

National Pharmacy Association (NPA) leaders have delivered a giant invoice for the £108m they say is owed to the sector for dispensing at a loss over the last month. And pharmacy owners can generate their own individual invoice using a new tool launched by the NPA, which indicates the funding shortfall for each pharmacy based […] The post NPA hands DHSC giant invoice for '£108m monthly shortfall' appeared first on The Pharmacist.

94
article thumbnail

Bayer cutbacks start to be felt with 1,500 jobs shed in Q1

pharmaphorum

Bayer's first-quarter results update shows its headcount has shrunk by around 1,500 since the start of the year, suggesting promised job cuts are starting to take hold

116
116
article thumbnail

Eisai sets new revenue target for Alzheimer’s drug Leqembi

BioPharma Dive

The annual forecast, which comes as Eisai and Biogen have begun submitting a more convenient form of Leqembi for approval, looks “more realistic” than previous guidance, according to Jefferies analysts.

98
article thumbnail

PulmCrit: Why the new study associating piptazo with increased mortality is wrong

EMCrit Project

Piperacillin-tazobactam is an antibiotic that a lot of people love to hate. Combine this with the conservatism that often (rightfully) surrounds drug safety, and it creates a lot of volatility. Before going further, we should review some recent history regarding piptazo. In the early 2010's, a series of retrospective correlational studies found that patients treated […] EMCrit Project by Josh Farkas.

91
article thumbnail

USDA, FDA turf battles hamper responses to outbreaks like H5N1 bird flu

STAT

WASHINGTON — On a bright June day in 2018, one of the nation’s top regulators waved groceries in the air, quizzing the secretary of agriculture on which agency is charged with monitoring different types of food. Scott Gottlieb, the commissioner of the Food and Drug Administration at the time, grinned widely as he held liquid egg whites and a carton of eggs.

363
363
article thumbnail

ARRS funding for DPPs could support community trainees

The Pharmacist

NHS England (NHSE) wants Additional Roles Reimbursement Scheme (ARRS) funding that has recently been unlocked for designated prescribing practitioners (DPPs) ‘to support trainee pharmacists across sectors of practice’, a conference has heard. Last week at the Clinical Pharmacy Congress (CPC) in London, a new opportunity to use ARRS funding for pharmacy training roles was announced. […] The post ARRS funding for DPPs could support community trainees appeared first on The Pharmacist.

104
104
article thumbnail

ICER raps conduct of Lykos’ psychedelic trial for PTSD

pharmaphorum

The Institute for Clinical and Economic Review (ICER) typically focuses on the cost-effectiveness of new therapies, but in an unusual move has sharply criticised the design and conduct of clinical trials of Lykos Therapeutics psychedelic therapy for post-traumatic stress disorder (PTSD).

110
110
article thumbnail

Cresset establishes new HQ in Bengaluru

Express Pharma

Cresset, a provider of solutions for Computational Drug Discovery and Development that accelerate research outcomes, is expanding its existing Asia Pacific presence by creating a new headquarters in Bengaluru, one of India’s leading centers for biotechnology and pharmaceutical research. The press release states that the new India site will support the growing demands of Cresset’s APAC customer base, and increase its reach in a range of markets across the region, including South Korea, Japan, Ch

96
article thumbnail

Rise of drug-resistant superbugs could make Covid pandemic look ‘minor’, expert warns

The Guardian - Pharmaceutical Industry

Common infections will kill millions if drug resistance through misuse of antibiotics is not curbed, says England’s ex-chief medical officer What is antimicrobial resistance and how big a problem is it? The Covid-19 pandemic will “look minor” compared with what humanity faces from the growing number of superbugs resistant to current drugs, Prof Dame Sally Davies, England’s former chief medical officer, has warned.

103
103
article thumbnail

STAT+: Analysis of pharmaceutical R&D ranks Novo Nordisk and Johnson & Johnson above their peers

STAT

When it comes to bringing an experimental drug to market and selling it, Novo Nordisk, the maker of the weight loss drug Wegovy, is tops, according to a new analysis. But if you want to invent lots of potential drugs that could eventually reach the market, you’d be far better off with Johnson & Johnson, Merck, or AstraZeneca. The analysis, the 13th edition of the Pharmaceutical Innovation and Invention Index, was produced by the consultancy Idea Pharma and released Thursday at the STA

311
311
article thumbnail

Patients 'put at risk' as pharmacies face medicine shortages 'multiple times a day'

The Pharmacist

Eight in 10 pharmacy team members report that medicine shortages are putting patients’ health at risk, according to a survey by Community Pharmacy England (CPE). The Pressures Survey, completed by more than 900 pharmacy owners and over 2,000 pharmacy team members, found that medicine supply issues were affecting the majority of pharmacy teams (72%) ‘multiple […] The post Patients 'put at risk' as pharmacies face medicine shortages 'multiple times a day' appeared first o

article thumbnail

FDA clears Roche self-collection system for HPV screening

pharmaphorum

The FDA has approved Roche's HPV self-sampling solution that the company says can tackle unequal access to screening that can put women at risk of cervical cancer

111
111
article thumbnail

AI in packaging and labelling processes

Express Pharma

Artificial Intelligence (AI) is an emerging digital technology-driven tool to support various processes from design and development to distribution and delivery of goods and services with improved quality, safety, security and punctuality, thereby helping to enhance consumer satisfaction and boost the trust-building process. Since there is no artificial or arbitrary element in it and the level of intelligence is enhanced in this programme, I call it Augmented Intelligence.

article thumbnail

FDA delays decision on Moderna RSV vaccine

BioPharma Dive

The regulator cited “administrative constraints,” rather than any issue with Moderna’s trial data, for missing a May 12 deadline, the company said.

Vaccines 106
article thumbnail

What we know about extreme heat’s health impacts after the hottest summer on record

STAT

Last summer’s heat waves demonstrated all the ways that extreme heat takes a toll on the human body. In cities across the U.S. from Phoenix to New York, people suffered from heat exhaustion, heat stroke, heat cramps, and more. In Texas, more than 300 people died from heat last year — the highest number since the state started tracking the deaths in 1989.

345
345
article thumbnail

CPE 'already working with DHSC' on implications of hub and spoke changes

The Pharmacist

Community Pharmacy England (CPE) has already begun working with the Department of Health and Social Care (DHSC) on how hub and spoke arrangements will work for NHS services in England, it has told The Pharmacist. This comes as the government plans to allow models of hub and spoke dispensing across different legal entities that could supply […] The post CPE 'already working with DHSC' on implications of hub and spoke changes appeared first on The Pharmacist.

article thumbnail

Ajit Singh, Jagjit Singh from ACG receive Lifetime Achievement Award from Hurun India

Express Pharma

Ajit Singh, Chairman, ACG and Jasjit Singh, Vice Chairman, ACG have received Lifetime Achievement Awards from Hurun India. The Singh brothers joined the ranks of previous recipients such as Cyrus and Adar Poonawala of Serum Institute of India, K Dinesh, Co-Founder, Infosys and Jalaj Dani, Co- Promoter, Asian Paints. The Singh brothers acknowledged the support received from the pharma industry, their families, the ACG Global Leadership, ACG team, ACG Cares Foundation, and their customers and supp

92
article thumbnail

iTeos shares jump on TIGIT update; Acelyrin swaps CEOs

BioPharma Dive

Interim data surpassed expectations, iTeos said. Elsewhere, Acelyrin revealed chief executive officer Shao-Lee Lin is departing and Bluebird bio gave a fuller account of its gene therapy launches.

101
101
article thumbnail

STAT+: Lawmaker accuses Amgen of placing profits above patients with dosing for a cancer drug

STAT

A U.S. lawmaker is accusing Amgen of “putting profits before patients” over its decision to continue marketing a high dose of a pricey cancer treatment instead of a lower dose that is less expensive and not as toxic to patients. At issue is a medication called Lumakras, which is used to treat non-small cell lung cancer and which won conditional regulatory approval three years ago.

Dosage 344
article thumbnail

King Charles III announced as new RPS patron

The Pharmacist

His Majesty King Charles III has become the new patron of the Royal Pharmaceutical Society (RPS), it has been announced. The news marks the first anniversary of the Coronation of His Majesty and has been welcomed by the RPS which said it was ‘grateful to the Royal family for their ongoing support’. The late Queen […] The post King Charles III announced as new RPS patron appeared first on The Pharmacist.

99
article thumbnail

Updated BIOSECURE Act draft clears House committee

pharmaphorum

House Oversight Committee passes BIOSECURE Act, which would restrict US companies from contracting with Chinese biotechs including WuXi AppTec, MGI and BGI

109
109
article thumbnail

Sartorius partners with Sanofi to commercialise biomanufacturing (ICB) platform

Express Pharma

Sartorius is collaborating with Sanofi biopharmaceutical to develop an end-to-end platform for integrated and continuous downstream bioprocessing. Selected as a preferred supplier, Sartorius will contribute its engineering and manufacturing expertise to commercialise ICB platforms based on prototypes developed by Sanofi. In return, Sanofi will grant Sartorius exclusive access to its know-how and patents related to the ICB platform.

90
article thumbnail

Real-life data highlights need for patient-centered management of unhealthy cholesterol

Outsourcing Pharma

The Global Heart Hub, an international alliance of heart patient organizations based in Ireland, has unveiled the first findings from their patient-led Insights from Patients living with Elevated Cholesterol (IPEC) data generation program.

87
article thumbnail

CDC launching wastewater dashboard to track bird flu virus spread

STAT

Reluctance among dairy farmers to report H5N1 bird flu outbreaks within their herds or allow testing of their workers has made it difficult to keep up with the virus’s rapid spread , prompting federal public health officials to look to wastewater to help fill in the gaps. On Monday, the Centers for Disease Control and Prevention is expected to unveil a public dashboard tracking influenza A viruses in sewage that the agency has been collecting from 600 wastewater treatment sites around the

363
363